Schuhler S, Clark A, Joseph W, Patel A, Lehnen K, Stratford E, Horan T L, Fone K C F, Ebling F J P
School of Biomedical Sciences, University of Nottingham, Nottingham, UK.
J Neuroendocrinol. 2005 May;17(5):276-85. doi: 10.1111/j.1365-2826.2005.01303.x.
The Siberian hamster provides a physiological model for understanding the hypothalamic control of energy metabolism as it undergoes annual photoperiod-regulated cycles of body weight (i.e. fattening in summer, and catabolism of fat stores in winter). As a first step to investigate whether enhanced serotonergic (5-HT) tone might underlie the catabolic processes in short days, we investigated whether serotonergic stimulation can produce catabolic actions in fat hamsters housed in long days. Acute treatment with the serotonin reuptake inhibitor (+/-) fenfluramine (8 mg/kg, i.p.) produced a prolonged, dose-dependent reduction in food intake in both photoperiods. Behavioural observations and radiotelemetry analyses revealed that this anorectic effect of fenfluramine was associated with short-term increases in locomotor activity and in core body temperature. In a subsequent series of studies, hamsters were pretreated with the 5-HT2C receptor antagonist SB242084 (4 mg/kg, i.p.). This 5-HT2C receptor antagonist completely blocked the anorectic actions of fenfluramine, but did not decrease the hyperthermia or hyperlocomotion induced by fenfluramine; thus, the anorectic actions of fenfluramine probably reflect actions via the 5-HT2C receptor. Consistent with these observations, treatment of hamsters with the 5-HT2C receptor agonist VER 3323 (10 mg/kg, i.p.) or the 5-HT1B/2C receptor agonist mCPP (3 mg/kg, i.p.) reduced food intake. The response to manipulation of serotonergic pathways was not affected by the ambient photoperiod in any of these studies. We conclude that the anorectic actions of fenfluramine are not an indirect consequence of serotonergic actions on arousal pathways, and that its actions on feeding in the Siberian hamster are most likely to be mediated by the 5-HT2C receptor.
西伯利亚仓鼠提供了一个生理模型,用于理解下丘脑对能量代谢的控制,因为它会经历由光周期调节的年度体重循环(即夏季增肥,冬季脂肪储备分解代谢)。作为研究增强的血清素能(5-羟色胺,5-HT)张力是否可能是短日照下分解代谢过程基础的第一步,我们研究了血清素能刺激是否能在长日照饲养的肥胖仓鼠中产生分解代谢作用。用血清素再摄取抑制剂(±)芬氟拉明(8毫克/千克,腹腔注射)进行急性处理,在两个光周期中均导致食物摄入量出现长时间的、剂量依赖性减少。行为观察和无线电遥测分析表明,芬氟拉明的这种厌食作用与运动活动和核心体温的短期升高有关。在随后的一系列研究中,仓鼠先用5-HT2C受体拮抗剂SB242084(4毫克/千克,腹腔注射)进行预处理。这种5-HT2C受体拮抗剂完全阻断了芬氟拉明的厌食作用,但并未降低芬氟拉明诱导的体温过高或运动亢进;因此,芬氟拉明的厌食作用可能反映了通过5-HT2C受体的作用。与这些观察结果一致,用5-HT2C受体激动剂VER 3323(10毫克/千克,腹腔注射)或5-HT1B/2C受体激动剂mCPP(3毫克/千克,腹腔注射)处理仓鼠会减少食物摄入量。在任何这些研究中,对血清素能途径操纵的反应均不受环境光周期的影响。我们得出结论,芬氟拉明的厌食作用不是血清素能对觉醒途径作用的间接后果,并且其对西伯利亚仓鼠进食的作用最有可能由5-HT2C受体介导。